Pancreatic Ductal Adenocarcinoma (mPDAC)
Oncology·MeSH: Neoplasm Metastasis
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| lsta1 | LISATA THERAPEUTICS, INC. (LSTA) |
Frequently asked questions
How many drugs are in development for Pancreatic Ductal Adenocarcinoma (mPDAC)?
BioSniper tracks 1 drug in development for Pancreatic Ductal Adenocarcinoma (mPDAC) across 1 company.
How many clinical trials target Pancreatic Ductal Adenocarcinoma (mPDAC)?
There are 1 clinical trial targeting Pancreatic Ductal Adenocarcinoma (mPDAC) tracked by BioSniper.
Deep-dive into Pancreatic Ductal Adenocarcinoma (mPDAC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis